MedPath

Cluster-Randomized Trial of Air Filtration and Ventilation to Reduce Covid19 Spread in Homes

Not Applicable
Conditions
Covid19
Interventions
Device: Filtration Fan
Behavioral: Safe-home pamphlet
Behavioral: Mid-week phone call
Registration Number
NCT05777720
Lead Sponsor
Stanford University
Brief Summary

Investigators are evaluating whether an intervention consisting of box-fans with MERV 16 filters ("filtration fans") and recommendations for improving ventilation in the home can reduce secondary spread of Covid19 from an index case to susceptible contacts within the home.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Household members live in a shared space (apartment, home) with others (as opposed to renting single rooms in a shared space, for example)
  • At least 3 other people live in the household aside from index case
Exclusion Criteria
  • If index case test positive day was over 2 days prior
  • If half or more household members are thought to be infected already
  • If household has fewer than 3 contacts interested in participating in the study
  • If fewer than 3 contacts are expected to be present in the house for a majority of the following 7 days

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
InterventionMid-week phone callFamilies are provided with one filtration fan unit per room in their home (and one for the index case; if the family lives in a studio, they would receive 2 units). Investigators will advise families on ventilation improvements in their home. Investigators will provide an instructional pamphlet that describes how the fans work and the importance of ventilation. Investigators will follow-up on day 3-4 to check in and run through a checklist to ensure the fans are working and ventilation improvements are being attempted. Investigators will give families a CO2 monitor to measure average CO2 levels in the home. Investigators will test family members at day 0-1 for baseline testing; and again on day 7 for assessing secondary transmission among susceptible contacts.
InterventionSafe-home pamphletFamilies are provided with one filtration fan unit per room in their home (and one for the index case; if the family lives in a studio, they would receive 2 units). Investigators will advise families on ventilation improvements in their home. Investigators will provide an instructional pamphlet that describes how the fans work and the importance of ventilation. Investigators will follow-up on day 3-4 to check in and run through a checklist to ensure the fans are working and ventilation improvements are being attempted. Investigators will give families a CO2 monitor to measure average CO2 levels in the home. Investigators will test family members at day 0-1 for baseline testing; and again on day 7 for assessing secondary transmission among susceptible contacts.
InterventionFiltration FanFamilies are provided with one filtration fan unit per room in their home (and one for the index case; if the family lives in a studio, they would receive 2 units). Investigators will advise families on ventilation improvements in their home. Investigators will provide an instructional pamphlet that describes how the fans work and the importance of ventilation. Investigators will follow-up on day 3-4 to check in and run through a checklist to ensure the fans are working and ventilation improvements are being attempted. Investigators will give families a CO2 monitor to measure average CO2 levels in the home. Investigators will test family members at day 0-1 for baseline testing; and again on day 7 for assessing secondary transmission among susceptible contacts.
Primary Outcome Measures
NameTimeMethod
Incidence of Covid197th day since enrollment in the trial

Investigators will measure the incidence of Covid19 in susceptible contacts on day 7.

Secondary Outcome Measures
NameTimeMethod
Average CO2 levels7 days

Investigators will measure 7 day average CO2 levels in the home (measured in parts per million)

Incidence of new upper respiratory symptoms7th day since enrollment in the trial

Investigators will measure reported new upper respiratory symptoms in susceptible contacts.

Trial Locations

Locations (2)

San Mateo Medical Center

🇺🇸

San Mateo, California, United States

Stanford University Medical Center

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath